This inventor holds 2 USPTO granted patents. Top assignee: Sankyo Company, Limited. Active years: 1997-1998.
Company Filing History:
Years Active: 1997-1998
Title: Kenji Momota: Innovator in Viral Treatment
Introduction
Kenji Momota is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of viral treatment through his innovative research and development. With a total of 2 patents, his work focuses on the treatment and prophylaxis of viral infections.
Latest Patents
Kenji Momota's latest patents include a composition and method for the treatment or prophylaxis of viral infections in mammals, particularly humans. The first patent describes a composition that consists of oligodeoxyribonucleic acid derivatives, which are designed to combat viral infections effectively. The second patent also involves modified oligodeoxyribonucleotides, providing a novel route to these compounds along with intermediates of broader utility.
Career Highlights
Kenji Momota is associated with Sankyo Company, Limited, where he continues to advance his research in viral treatments. His work has garnered attention for its potential impact on public health and the treatment of viral diseases.
Collaborations
Kenji has collaborated with notable coworkers, including Hidehiko Furukawa and Hitoshi Hotoda, who have contributed to his research endeavors.
Conclusion
Kenji Momota's innovative work in the field of viral treatment showcases his dedication to improving health outcomes through scientific advancements. His contributions are significant in the ongoing fight against viral infections.